Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending March 29, 2020 Reports suggest possible in utero transmission of novel coronavirus 2019, Live zoster vaccine confers limited protection during tofacitinib therapy, More must reads Must reads for theWeek ending March 22, 2020 Lopinavir/ritonavir trial results ‘disappointing’ for severe COVID-19, Patients with COVID-19 may face risk for liver injury, COVID-19 in China: Children have less severe disease, but are vulnerable, African Americans with SLE face increased risk of CVD hospitalizations, High CV event risk seen in SLE patients with ACC/AHA-defined hypertension, More must readsMust reads for theWeek ending March 8, 2020 New RA diagnosis prompts patients to quit smoking, RA magnifies fragility fracture risk in ESRD, Antibodies affect gum disease in rheumatoid arthritis, RA patients report limited activity at 3 on a 0-10 pain scale, Rheumatoid factor status changed in RA patients during 1985-2014, More must readsMust reads for theWeek ending March 8, 2020 New RA diagnosis prompts patients to quit smoking, RA magnifies fragility fracture risk in ESRD, Antibodies affect gum disease in rheumatoid arthritis, RA patients report limited activity at 3 on a 0-10 pain scale, Rheumatoid factor status changed in RA patients during 1985-2014, More must readsMust reads for theWeek ending March 1, 2020 Comparison shows tighter treat-to-target approach provides better outcomes in RA, Specific markers detect psoriatic disease inflammation without elevated CRP, Vitamin D supplements in pregnancy boost bone health in offspring, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 last »
